Inflammation News and Research

RSS

Trial identifies a drug that may benefit some patients hospitalized with COVID-19 pneumonia

A proof-of-concept trial led by the Universities of Birmingham and University Hospitals Birmingham NHS Foundation Trust has identified a drug that may offer benefit some patients hospitalized with COVID-19 pneumonia.

18 Dec 2021

University of Birmingham launches 5 new major studies focused on management of type 1 diabetes

The University of Birmingham today announces the launch of five new major studies aimed at improving the prevention, treatment and management of type 1 diabetes – with a particular focus on children and young adults.

17 Dec 2021

Long-term characteristics of long-COVID following hospitalization

A new study demonstrates the urgent need for healthcare services to support this huge and quickly growing patient population, which has a significant burden of symptoms, lower exercise ability, and significant reductions in health-related quality of life after one year.

17 Dec 2021

Study: Common gene mutation for Parkinson's disease drives mislocalization of iron in the brain

A common gene mutation for Parkinson's disease drives mislocalization of iron in activated microglia, according to a new study publishing December 16th in the open-access journal PLOS Biology, by Mark Cookson of the National Institute on Aging and colleagues

17 Dec 2021

Study provides a more effective treatment approach to preventing graft-versus-host-disease

A new study led by UC Davis Health researchers showed that blocking IL-6 and TNF cytokines provides a more effective approach to preventing life-threatening graft-versus-host-disease (GVHD), an inflammatory condition that develops in patients after their allogeneic hematopoietic stem cell transplantation (allo-HSCT).

16 Dec 2021

ACTG announces the launch of clinical trial to evaluate new CMV vaccine in adults

The AIDS Clinical Trials Group (ACTG), the largest global HIV research network, today announced the launch of A5355, a clinical trial studying a new cytomegalovirus (CMV) vaccine in adults with both HIV and CMV.

16 Dec 2021

Experimental and computational synergy considered a promising approach in COVID-19 patients

Thanks to the large amount of -omics data becoming increasingly available, sophisticated computational models are developed for new fields such as immunology and the predictions they generate will help identify key molecules in inflammatory processes.

16 Dec 2021

Research provides reassuring data on the risk of heart inflammation after SARS-CoV-2 vaccination

A study published by The BMJ today provides more reassuring data on the risk of heart inflammation (myocarditis or myopericarditis) after mRNA vaccination against the covid-19 virus.

16 Dec 2021

Researchers identify two new AMD drug candidates using a stem-cell-derived model

Using a stem-cell-derived model, researchers have identified two drug candidates that may slow dry age-related macular degeneration (AMD), a leading cause of blindness for which no treatment exists.

15 Dec 2021

How SARS-CoV-2 affects the male reproductive system

Researchers review the potentially harmful consequences on the male reproductive system in COVID-19 patients.

15 Dec 2021

Discovery can pave the way for new strategies to reduce atherosclerosis using omega-3 fatty acids

A receptor activated by substances formed from omega-3 fatty acids plays a vital role in preventing inflammation in blood vessels and reducing atherosclerosis, a new study from Karolinska Institutet in Sweden published in The Journal of Clinical Investigation reports.

15 Dec 2021

Combination of gallic acid and stretching decreases arthritis inflammation markers in the cells

A healthy diet and a little exercise appear to be good for arthritis, even on the cellular level.

15 Dec 2021

Scientists develop novel method to monitor remote immune processes within cells

Our immune systems work hard to keep us healthy and to protect us against bacteria, viruses, fungi, parasites and cancerous cells.

15 Dec 2021

Impact of exogenous antibody therapy by convalescent plasma against SARS-CoV-2

Researches have been investigating the possibility of using convalescent plasma to help patients recover from COVID-19.

15 Dec 2021

Cell surface expression of SARS-CoV-2 nucleocapsid protein and its role in immunity

Researchers demonstrated the unexpected roles of nucleocapsid protein in innate and adaptive immunity to SARS-CoV-2.

15 Dec 2021

Hyperbaric oxygen treatment quickly resolves severe breathing difficulties in COVID-19 patients

High pressure (hyperbaric) oxygen resolves severe breathing difficulties in COVID-19 patients much more quickly than standard therapy, taking an average of 3 rather than 9 days, reveal the results of a small comparative clinical trial published online in Emergency Medicine Journal.

15 Dec 2021

Thrombosis may increase mortality risk in hospitalized COVID-19 patients

A team of US-based scientists has recently explored various risk factors associated with the poor prognosis of coronavirus disease 2019 (COVID-19). They have identified thrombosis-related risk factors as a major predictor of in-hospital COVID-19 related mortality. The study is currently available on the medRxiv* preprint server while awaiting peer review.

14 Dec 2021

11 exceptional recipients of the 2021 Lupus Innovation Award announced

The Lupus Research Alliance proudly announced today 11 research grant recipients in the U.S. and around the world of the 2021 Lupus Innovation Award which will fund wide ranging areas from probing the development and progression of lupus to pointing to potential personalized therapies.

14 Dec 2021

UVA research sheds light on why fecal transplant can benefit patients with C. difficile infections

New research from the University of Virginia School of Medicine sheds light on why a fecal transplant can benefit patients with dangerous recurrent C. difficile infections – and suggests a way to improve patient outcomes.

14 Dec 2021

Study may offer insights into novel therapeutic strategies to treat COVID-19 related blood clots

Blood clots or thromboembolic complications in patients with COVID-19 are associated with increased levels of various proteins that cause blood to clot, compared with people with blood clots unrelated to COVID-19, according to a small study by Yale Cancer Center researchers.

14 Dec 2021

Inflammation News and Research

Trial identifies a drug that may benefit some patients hospitalized with COVID-19 pneumonia

University of Birmingham launches 5 new major studies focused on management of type 1 diabetes

Long-term characteristics of long-COVID following hospitalization

Study: Common gene mutation for Parkinson's disease drives mislocalization of iron in the brain

Study provides a more effective treatment approach to preventing graft-versus-host-disease

ACTG announces the launch of clinical trial to evaluate new CMV vaccine in adults

Experimental and computational synergy considered a promising approach in COVID-19 patients

Research provides reassuring data on the risk of heart inflammation after SARS-CoV-2 vaccination

Researchers identify two new AMD drug candidates using a stem-cell-derived model

How SARS-CoV-2 affects the male reproductive system

Discovery can pave the way for new strategies to reduce atherosclerosis using omega-3 fatty acids

Combination of gallic acid and stretching decreases arthritis inflammation markers in the cells

Scientists develop novel method to monitor remote immune processes within cells

Impact of exogenous antibody therapy by convalescent plasma against SARS-CoV-2

Cell surface expression of SARS-CoV-2 nucleocapsid protein and its role in immunity

Hyperbaric oxygen treatment quickly resolves severe breathing difficulties in COVID-19 patients

Thrombosis may increase mortality risk in hospitalized COVID-19 patients

11 exceptional recipients of the 2021 Lupus Innovation Award announced

UVA research sheds light on why fecal transplant can benefit patients with C. difficile infections

Study may offer insights into novel therapeutic strategies to treat COVID-19 related blood clots

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News